CellaVision AB Total Assets

Latest as of December 2025: Skr1.09 Billion SEK ≈ $117.83 Million USD

CellaVision AB total assets. Based on the latest financial reports, CellaVision AB (CEVI) holds total assets worth Skr1.09 Billion SEK (≈ $117.83 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is CellaVision AB worth for the company's overall valuation and market capitalisation.

Total Assets of CellaVision AB (2000–2025)

Total assets of CellaVision AB from 2000 to 2025. This chart illustrates how CellaVision AB's total assets have evolved over time, based on quarterly financial data. See CellaVision AB (CEVI) share price today for real-time trading data and today's change.

CellaVision AB - Asset Composition Analysis

CellaVision AB Total Assets Breakdown (December 2025)

CellaVision AB total assets breakdown as of December 2025. CellaVision AB's total assets of Skr1.09 Billion consist of 40.3% current assets and 59.7% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr0.00	17.2%
Accounts Receivable	Skr141.07 Million	12.9%
Inventory	Skr111.81 Million	10.2%
Property, Plant & Equipment	Skr122.37 Million	11.2%
Intangible Assets	Skr408.20 Million	37.3%
Goodwill	Skr120.68 Million	11.0%

Asset Composition Trend (2000–2025)

This chart illustrates how CellaVision AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CellaVision AB (CEVI) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: CellaVision AB's current assets represent 40.3% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 17.2% of total assets in 2025, down from 71.5% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 0.0% in 2000.
Asset Diversification: The largest asset category is intangible assets at 37.3% of total assets.

CellaVision AB Competitors by Total Assets

Key competitors of CellaVision AB based on total assets are shown below.

Company	Country	Total Assets
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Double Medical Technology Inc SHE:002901	China	CN¥5.03 Billion
BMC Medical Co. Ltd. A SHE:301367	China	CN¥3.59 Billion
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$96.98 Million
Emvision Medical Devices Ltd AU:EMV	Australia	AU$24.94 Million
Sequana Medical NV BR:SEQUA	Belgium	€14.57 Million
Hironic Co. Ltd KQ:149980	Korea	₩80.01 Billion
DRGEM Corporation KQ:263690	Korea	₩131.65 Billion

CellaVision AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.98	3.72	2.87
Quick Ratio	2.97	2.56	2.14
Cash Ratio	0.00	0.00	0.00
Working Capital	Skr330.17 Million	Skr293.70 Million	Skr213.17 Million

CellaVision AB - Advanced Valuation Insights

This section examines the relationship between CellaVision AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.01
Latest Market Cap to Assets Ratio	0.45
Asset Growth Rate (YoY)	8.2%
Total Assets	Skr1.09 Billion
Market Capitalization	$490.26 Million USD

Valuation Analysis

Below Book Valuation: The market values CellaVision AB's assets below their book value (0.45x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: CellaVision AB's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for CellaVision AB (2000–2025)

The table below shows the annual total assets of CellaVision AB from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	Skr1.09 Billion ≈ $117.83 Million	+8.20%
2024-12-31	Skr1.01 Billion ≈ $108.90 Million	+8.96%
2023-12-31	Skr928.71 Million ≈ $99.94 Million	+4.15%
2022-12-31	Skr891.75 Million ≈ $95.97 Million	+8.06%
2021-12-31	Skr825.21 Million ≈ $88.81 Million	+23.53%
2020-12-31	Skr668.02 Million ≈ $71.89 Million	+4.10%
2019-12-31	Skr641.71 Million ≈ $69.06 Million	+72.14%
2018-12-31	Skr372.78 Million ≈ $40.12 Million	+24.01%
2017-12-31	Skr300.60 Million ≈ $32.35 Million	+17.22%
2016-12-31	Skr256.44 Million ≈ $27.60 Million	+16.34%
2015-12-31	Skr220.43 Million ≈ $23.72 Million	+8.99%
2014-12-31	Skr202.25 Million ≈ $21.77 Million	+7.25%
2013-12-31	Skr188.57 Million ≈ $20.29 Million	+5.61%
2012-12-31	Skr178.56 Million ≈ $19.22 Million	-0.10%
2011-12-31	Skr178.73 Million ≈ $19.23 Million	+9.99%
2010-12-31	Skr162.50 Million ≈ $17.49 Million	+43.36%
2009-12-31	Skr113.35 Million ≈ $12.20 Million	+17.50%
2008-12-31	Skr96.47 Million ≈ $10.38 Million	+118.66%
2007-12-31	Skr44.12 Million ≈ $4.75 Million	+6.75%
2006-12-31	Skr41.33 Million ≈ $4.45 Million	-10.62%
2005-12-31	Skr46.24 Million ≈ $4.98 Million	+2.49%
2004-12-31	Skr45.12 Million ≈ $4.86 Million	+47.78%
2003-12-31	Skr30.53 Million ≈ $3.29 Million	-58.57%
2002-12-31	Skr73.69 Million ≈ $7.93 Million	-36.12%
2001-12-31	Skr115.35 Million ≈ $12.41 Million	+35.89%
2000-12-31	Skr84.89 Million ≈ $9.13 Million	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$490.26 Million

Skr4.56 Billion SEK

Market Cap Rank

#11968 Global

#197 in Sweden

Share Price

Skr191.00

Change (1 day)

-0.21%

52-Week Range

Skr118.40 - Skr195.60

All Time High

Skr478.48